Celebrity Inventors
Actress Jamie Lee Curtis is a patented inventor - she created a diaper equipped with a premoistened baby wipe. And that's no act!
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7709666 | Transgenic plants containing altered levels of sterol compounds and tocopherols Provided are recombinant constructs comprising DNA sequences encoding enzymes effective in altering the biosynthesis and accumulation of sterol compounds and tocopherols in transgenic plants. Also provided are methods of using such constructs to produce transgenic p... | 05/04/2010 |
| 7396946 | Compound for treatment of external secretion disorders Disclosed is a method for treatment of external secretion disorders, which comprises administering a fatty 5 acid derivative to a subject in need of said treatment. The method of the present invention is useful for treatment of at least one condition selected from h... | 07/08/2008 |
| 7132453 | Method of using prostacyclin to treat respiratory syncytial virus infections The present invention discloses methods and a kit for treating a respiratory syncytial virus infection. The method comprises providing an infection modulator, and administering a therapeutically effective amount of the infection modulator, wherein the respiratory sy... | 11/07/2006 |
| 6972123 | Polymeric castor polyester quaternary compounds based upon dimer acid The present invention deals with the certain castor polyesters that give high gloss when applied to the skin. Said ester are the reaction of the hydroxyl group of castor oil with less than one equivalent of a fatty acid then in a subsequently step the remainder of a... | 12/06/2005 |
| 6953849 | Process for the isolation of glycolipids The present invention relates to a process for the isolation of a glycolipid enriched fraction from rice bran oil by subjecting crude rice bran oil to at least two steps of dewaxing/degumming, treating sludge obtained as a byproduct of the second said dewaxing/degum... | 10/11/2005 |
| 6933289 | Inhibition of irritating side effects associated with use of a topical ophthalmic medication This invention relates to a method of reducing an irritating or adverse side effect associated with the topical use of an active ophthalmic drug comprising incorporating an effective amount of a cyclodextrin or cyclodextrin derivative into a formulation to complex t... | 08/23/2005 |
| 6878522 | Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 The present invention relates to the discovery that PDG2 is the nautral ligand for orphan receptor CRTH2, which interaction, it will now immediately be recognized, is important in the development of valuable pharmaceuticals. The present invention is there... | 04/12/2005 |
| 6713268 | Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation Methods to identify agents having ocular hypotensive activity which have reduced or absent ability to stimulate iridial hyperpigmentation are disclosed. The methods reside in part in detecting the ability of a test compound to interact with the FP receptor. ... | 03/30/2004 |
| 6403817 | Method for preparing prostaglandin E-type compound The present invention discloses a method for preparing a prostaglandin E-type compound, in which prostaglandin F-type compound is used as an initiator to generate novel derivative of prostaglandin F-type compound through a silylation reaction, and eventua... | 06/11/2002 |
| 6239298 | Fuel lubricity additives There is disclosed a fuel lubricity additive, made by a two-step process wherein the first step is co-reacting an unsaturated base oil, predominantly from vegetable oil sources, and a compound having a diene structure and a carboxylic acid group, wherein ... | 05/29/2001 |
| 6083501 | Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases A drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation, as well as a model animal of fibrinoid formation or thrombus formation in the lung is disclosed. The drug for preventing and treating diseases caused by fib... | 07/04/2000 |
| 5990346 | Prostaglandins and processes for production thereof A prostaglandin having formula (I), (II), or (III): ##STR1## a process of production thereof, and inhibitors of cell migration caused by chemokines containing (I) or (II) as an active ingredient.... | 11/23/1999 |
| 5750750 | High viscosity complex alcohol esters A complex alcohol ester which comprises the reaction product of an add mixture of the following: a polyhydroxyl compound represented by the general formula: R(OH)n wherein R is any aliphatic or cyclo-aliphatic hydrocarbyl group and n is at leas... | 05/12/1998 |
| 5639899 | Prostaglandin E1 analogues Object: To provide novel prostaglandin E1 analogues which have more excellent pharmaceutical effects, longer duration of the effects and less side-effects than the prior art prostaglandin E1 's. Constitution: A PGE1 analogue re... | 06/17/1997 |
| 5292915 | Compounds containing carbonate groups and carbonyl groups and the preparation and use thereof The invention relates to compounds containing carbonate groups and carbonyl groups and having the general formula ##STR1## in which R stands for a C1 -C4 -alkyl radical, an aryl radical, or a radical R1, where R1... | 03/08/1994 |
| 5212324 | Treatment of cataract with 15-keto-prostaglandin compounds A compound for treatment of a cataract which is a 15-ketoprostaglandin compound.... | 05/18/1993 |
| 5053525 | Oxo-analogs of mevinolin-like antihyper-cholesterolemic agents Mevinolin-like compounds in which the lactone is opened and the hydroxyl function produced thereby is replaced by an oxo function are potent HMG-CoA reductase inhibitors possessing one less asymmetric center.... | 10/01/1991 |
| 5045586 | Lubricants for thermoplastic resins The present invention is directed to branched polyesters derived from the reaction product of hydroxy stearic acid or hydroxy stearic alkoxylate, a guerbet alochol or guerbet alcohol alkoxylate, which product is further reacted with a polycarboxylic acid ... | 09/03/1991 |
| 4523042 | Derivatives of alpha-alkyl polyolefinic carboxylic acid useful in the treatment of psoriasis This invention relates to novel compounds having pharmaceutical activity and having the general structure ##STR1## wherein the Z, R1, R2, R3, R4, n and m are defined within.... | 06/11/1985 |
| 4404393 | 15-Deoxy-16-hydroxy-16-(1'fluorovinyl) prostaglandins and derivatives 15-Deoxy-16-(halovinyl)-16-hydroxy prostaglandins have been prepared.... | 09/13/1983 |
| 4363817 | Enol acylate analogs of E1 and E2 prostaglandins Disclosed are C-9 enol acylate analogs of E1 and E2 prostaglandins which are variously useful as bronchodilators, gastric anti-secretory agents and cyto-protective agents.... | 12/14/1982 |
| 4349690 | 9-Deoxy-9-methylene-6-keto-PGE-type compounds The present invention provides novel 9-deoxy-9-methylene-6-keto-PGE derivatives which are useful for platelet aggregation inhibition and gastric cyctoprotection.... | 09/14/1982 |
| 4302596 | 13,14-Didehydro-11-deoxy-9-deoxy-9-methylene-19-oxo-PGF2 compounds The present invention provides novel 13,14-didehydro-11-deoxy-9-deoxy-9-methylene-19-oxo-PGF2 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.... | 11/24/1981 |
| 4296250 | 13,14-Dihydro-9-deoxy-9-methylene-19-oxo-PGF1 compounds The present invention provides novel 13,14-dihydro-9-deoxy-9-methylene-19-oxo-PGF1 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.... | 10/20/1981 |
| 4296249 | 13,14-Dihydro-11-deoxy-9-deoxy-9-methylene-19-oxo-PGE1 compounds The present invention provides novel 13,14-dihydro-11-deoxy-9-deoxy-9-methylene-19-oxo-PGF1 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.... | 10/20/1981 |
| 4296247 | 13,14-Dihydro-11-deoxy-11-hydroxymethyl-9-deoxy-9-methylene-19-oxo-PGF.sub. 1 The present invention provides novel 13,14-dihydro-11-deoxy-11-hydroxymethyl-9-deoxy-9-methylene-19-oxo-PGF.sub .1 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.... | 10/20/1981 |
| 4296246 | 13,14-Didehydro-11-deoxy-11-hydroxymethyl-19-oxo-PGF1 compounds The present invention provides novel 13,14-didehydro-11-deoxy-11-hydroxymethyl-19-oxo-PGF1 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.... | 10/20/1981 |
| 4294984 | 13,14-Didehydro-11-deo xy-11-hydroxymethyl-9-deoxy-9-methylene-19-oxo-PGF1 compounds The present invention provides novel 13,14-didehydro-11-deoxy-11-hydroxymethyl-9-deoxy-9-methylene-19-oxo-PGF.s ub.1 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.... | 10/13/1981 |
| 4294983 | 13,14-Didehydro-11-deoxy-19-oxo-PGF1 compounds The present invention provides novel 13,14-didehydro-11-deoxy-19-oxo-PGF1 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.... | 10/13/1981 |
| 4294981 | 13,14-Didehydro-11-deoxy-9-deoxy-9-methylene-19-oxo-PGF1 compounds The present invention provides novel 13,14-didehydro-11-deoxy-9-deoxy-9-methylene-19-oxo-PGF1 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.... | 10/13/1981 |
| 4294980 | 13,14-Dihydro-11-deoxy-11-hydroxymethyl-19-oxo-PGF1 compounds The present invention provides novel 13,14-dihydro-11-deoxy-11-hydroxymethyl-19-oxo-PGF1 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.... | 10/13/1981 |
| 4294978 | 13,14-Didehydro-19-oxo-PGF2 compounds The present invention provides novel 13,14-didehydro-19-oxo-PGF2 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.... | 10/13/1981 |
| 4293710 | 13,14-Dihydro-11-deoxy-11-hydroxymethyl-19-oxo-PGF2 compounds The present invention provides novel 13,14-dihydro-11-deoxy-11-hydroxymethyl-19-oxo-PGF2 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications. DESCRIPTION... | 10/06/1981 |
| 4293709 | 13,14-Dihydro-9-deoxy-9-methylene-19-oxo-PGF2 compounds The present invention provides novel 13,14-dihydro-9-deoxy-9-methylene-19-oxo-PGF2 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.... | 10/06/1981 |
| 4292438 | 13,14-Didehydro-9-deoxy-9-methylene-19-oxo-PGF2 compounds The present invention provides novel 13,14-didehydro-9-deoxy-9-methylene-19-oxo-PGF2 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.... | 09/29/1981 |
| 4292441 | 13,14-Didehydro-11-deo xy-11-hydroxymethyl-9-deoxy-9-methylene-19-oxo-PGF2 compounds The present invention provides novel 13,14-didehydro-11-deoxy-11-hydroxymethyl-9-deoxy-9-methylene-19-oxo-PGF.s ub.2 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.... | 09/29/1981 |
| 4292442 | 13,14-Didehydro-11-deoxy-19-oxo-PGF2 compounds The present invention provides novel 13,14-didehydro-11-deoxy-19-oxo-PGF2 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.... | 09/29/1981 |
| 4292440 | 13,14-Didehydro-9-deoxy-9-methylene-19-oxo-PGF1 compounds The present invention provides novel 13,14-didehydro-9-deoxy-9-methylene-19-oxo-PGF1 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.... | 09/29/1981 |
| 4289901 | 13,14-Dihydro-11-deoxy-19-oxo-PGF1 compounds The present invention provides novel 13,14-dihydro-11-deoxy-19-oxo-PGF1 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.... | 09/15/1981 |
| 4288617 | 13,14-Didehydro-19-oxo-PGF1 compounds The present invention provides novel 13,14-didehydro-19-oxo-PGF1 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.... | 09/08/1981 |
